XASXRHC
Market cap4.93bUSD
Dec 20, Last price
34.40AUD
1D
-1.09%
1Q
-14.64%
Jan 2017
-49.63%
Name
Ramsay Health Care Ltd
Chart & Performance
Profile
Ramsay Health Care Limited owns and operates hospitals for public and private patients. It also offers health care services. It operates facilities in 460 locations in the Asia Pacific, the United Kingdom, France, and Nordics. The company was founded in 1964 and is based in Sydney, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | 2015‑06 | |
Income | ||||||||||
Revenues | 16,665,400 12.13% | 14,863,000 13.61% | 13,082,100 5.94% | |||||||
Cost of revenue | 15,728,500 | 12,778,700 | 11,417,300 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 936,900 | 2,084,300 | 1,664,800 | |||||||
NOPBT Margin | 5.62% | 14.02% | 12.73% | |||||||
Operating Taxes | 121,300 | 181,500 | 159,300 | |||||||
Tax Rate | 12.95% | 8.71% | 9.57% | |||||||
NOPAT | 815,600 | 1,902,800 | 1,505,500 | |||||||
Net income | 888,700 198.12% | 298,100 8.80% | 274,000 -38.98% | |||||||
Dividends | (158,300) | (218,700) | (351,900) | |||||||
Dividend yield | 1.46% | 1.70% | 2.10% | |||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 605,700 | 486,800 | 397,600 | |||||||
Long-term debt | 16,186,500 | 17,354,400 | 15,783,500 | |||||||
Deferred revenue | 6,499,900 | 5,786,700 | ||||||||
Other long-term liabilities | 579,000 | 997,100 | (5,173,500) | |||||||
Net debt | 15,905,400 | 17,101,500 | 15,528,000 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 1,302,000 | 1,279,600 | 715,500 | |||||||
CAPEX | (753,800) | (720,900) | (708,500) | |||||||
Cash from investing activities | 150,500 | (713,800) | 30,000 | |||||||
Cash from financing activities | (1,450,100) | (242,400) | (1,410,900) | |||||||
FCF | 1,290,600 | 422,200 | 2,156,200 | |||||||
Balance | ||||||||||
Cash | 662,300 | 656,100 | 314,200 | |||||||
Long term investments | 224,500 | 83,600 | 338,900 | |||||||
Excess cash | 53,530 | |||||||||
Stockholders' equity | 5,590,500 | 8,826,300 | 8,432,500 | |||||||
Invested Capital | 16,991,070 | 17,834,700 | 15,736,100 | |||||||
ROIC | 4.68% | 11.34% | 9.79% | |||||||
ROCE | 5.27% | 11.46% | 10.38% | |||||||
EV | ||||||||||
Common stock shares outstanding | 228,900 | 228,400 | 228,300 | |||||||
Price | 47.46 -15.69% | 56.29 -23.14% | 73.24 16.35% | |||||||
Market cap | 10,863,594 -15.50% | 12,856,636 -23.11% | 16,720,692 16.30% | |||||||
EV | 27,651,094 | 34,881,836 | 36,999,892 | |||||||
EBITDA | 936,900 | 3,046,600 | 2,571,700 | |||||||
EV/EBITDA | 29.51 | 11.45 | 14.39 | |||||||
Interest | 620,000 | 261,200 | 146,800 | |||||||
Interest/NOPBT | 66.18% | 12.53% | 8.82% |